Displaying 101 - 101 of 101 results
Released Company Title Industry Topic
15 Sep 2023
07:00 CEST
ARGENX SE argenx Announces Positive CHMP Opinion for Subcutaneous Efgartigimod for Generalized Myasthenia Gravis 20103010 Biotechnology Other subject